• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何通过磁共振成像区分良性和恶性子宫肌肿瘤。

How to differentiate benign from malignant myometrial tumours using MR imaging.

机构信息

Department of Radiology, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris and Université Pierre et Marie Curie, Paris, France.

出版信息

Eur Radiol. 2013 Aug;23(8):2306-14. doi: 10.1007/s00330-013-2819-9. Epub 2013 Apr 8.

DOI:10.1007/s00330-013-2819-9
PMID:23563602
Abstract

PURPOSE

To retrospectively evaluate the ability of magnetic resonance imaging (MRI) to differentiate malignant from benign myometrial tumours.

METHODS

Fifty-one women underwent MRI before surgery for evaluation of a solitary myometrial tumour. At histopathology, there were 25 uncertain or malignant mesenchymal tumours and 26 benign leiomyomas. Conventional morphological MRI criteria were recorded in addition to b 1,000 signal intensity and apparent diffusion coefficient (ADC). Odds ratios (OR) were calculated for each criterion. A multivariate analysis was performed to construct an interpretation model.

RESULTS

The significant criteria for prediction of malignancy were high b 1,000 signal intensity (OR = +∞), intermediate T2-weighted signal intensity (OR = +∞), mean ADC (OR = 25.1), patient age (OR = 20.1), intra-tumoral haemorrhage (OR = 21.35), endometrial thickening (OR = 11), T2-weighted signal heterogeneity (OR = 10.2), menopausal status (OR = 9.7), heterogeneous enhancement (OR = 8) and non-myometrial origin on MRI (OR = 4.9). In the recursive partitioning model, using b 1,000 signal intensity, T2 signal intensity, mean ADC, and patient age, the model correctly classified benign and malignant tumours in 47 of the 51 cases (92.4 %).

CONCLUSION

We have developed an interpretation model usable in routine practice for myometrial tumours discovered at MRI including T2 signal, b 1,000 signal and ADC measurement.

KEY POINTS

• MRI is widely used to differentiate benign from malignant myometrial tumours. • By combining T2-weighted, b 1,000 and ADC features, MRI is 92.4 % accurate. • DWI may limit misdiagnoses of uterine sarcoma as benign leiomyoma. • Patient age is important when considering a solitary myometrial tumour.

摘要

目的

回顾性评估磁共振成像(MRI)鉴别子宫肌层良恶性肿瘤的能力。

方法

51 名女性因单发子宫肌层肿瘤接受 MRI 检查。在组织病理学上,有 25 例不确定或恶性间叶性肿瘤和 26 例良性平滑肌瘤。除了 b 值为 1000 的信号强度和表观扩散系数(ADC)外,还记录了常规形态学 MRI 标准。为每个标准计算了优势比(OR)。进行了多变量分析以构建解释模型。

结果

用于预测恶性肿瘤的显著标准是高 b 值为 1000 的信号强度(OR=+∞)、中等 T2 加权信号强度(OR=+∞)、平均 ADC(OR=25.1)、患者年龄(OR=20.1)、肿瘤内出血(OR=21.35)、子宫内膜增厚(OR=11)、T2 加权信号异质性(OR=10.2)、绝经状态(OR=9.7)、不均匀强化(OR=8)和 MRI 上的非子宫肌层起源(OR=4.9)。在递归分割模型中,使用 b 值为 1000 的信号强度、T2 信号强度、平均 ADC 和患者年龄,该模型正确分类了 51 例中的 47 例(92.4%)良性和恶性肿瘤。

结论

我们已经开发了一种解释模型,可用于包括 T2 信号、b 值为 1000 的信号和 ADC 测量在内的 MRI 发现的子宫肌层肿瘤的常规实践。

关键点

  1. MRI 广泛用于鉴别子宫肌层的良恶性肿瘤。

  2. 通过结合 T2 加权、b 值为 1000 的信号和 ADC 特征,MRI 的准确率为 92.4%。

  3. DWI 可能会限制将子宫肉瘤误诊为良性平滑肌瘤。

  4. 当考虑单发子宫肌层肿瘤时,患者年龄很重要。

相似文献

1
How to differentiate benign from malignant myometrial tumours using MR imaging.如何通过磁共振成像区分良性和恶性子宫肌肿瘤。
Eur Radiol. 2013 Aug;23(8):2306-14. doi: 10.1007/s00330-013-2819-9. Epub 2013 Apr 8.
2
Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.联合使用 T2 加权和弥散加权 3-T MR 成像区分子宫肉瘤和良性平滑肌瘤。
Eur Radiol. 2009 Nov;19(11):2756-64. doi: 10.1007/s00330-009-1471-x. Epub 2009 Jun 6.
3
Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.超声检查和磁共振成像在子宫间质肿瘤特征描述中的价值。
Acta Obstet Gynecol Scand. 2014 Mar;93(3):261-8. doi: 10.1111/aogs.12325.
4
Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.T2加权磁共振成像上子宫肌层高信号肿块:与扩散加权磁共振成像的鉴别诊断
J Comput Assist Tomogr. 2009 Nov-Dec;33(6):834-7. doi: 10.1097/RCT.0b013e318197ec6f.
5
Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.3T MR 波谱分析、弥散加权 MRI 及表观弥散系数值对鉴别子宫肌层良恶性肿瘤的诊断价值。
Clin Radiol. 2019 Jul;74(7):571.e9-571.e18. doi: 10.1016/j.crad.2019.03.011. Epub 2019 Apr 20.
6
Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.基于弥散加权 MRI 的鉴别诊断良性非典型性平滑肌瘤与恶性子宫肉瘤的诊断算法。
Radiology. 2020 Nov;297(2):361-371. doi: 10.1148/radiol.2020191658. Epub 2020 Sep 15.
7
Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.平滑肌瘤或肉瘤?超声检查可疑的子宫肿块的 MRI 表现鉴别诊断。
Eur J Radiol. 2024 Jan;170:111217. doi: 10.1016/j.ejrad.2023.111217. Epub 2023 Nov 25.
8
T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?T2 高信号子宫肿瘤:磁共振成像特征能否区分平滑肌瘤和平滑肌肉瘤?
Abdom Radiol (NY). 2019 Oct;44(10):3388-3397. doi: 10.1007/s00261-019-02097-x.
9
Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.探讨以腰大肌和子宫外肌作为内参照在 3T MRI 下基于 T2 加权和对比增强 MRI 的定量参数对子宫肉瘤与子宫肌瘤的鉴别诊断价值。
Cancer Imaging. 2019 Apr 1;19(1):20. doi: 10.1186/s40644-019-0206-8.
10
The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.磁共振扩散加权成像在鉴别子宫肉瘤与良性平滑肌瘤中的应用。
Eur Radiol. 2008 Apr;18(4):723-30. doi: 10.1007/s00330-007-0787-7. Epub 2007 Oct 10.

引用本文的文献

1
Focal Area of Low T2 Signal on MRI Scans in a Heterogeneous Uterine Leiomyoma Does Not Exclude the Possibility of Malignancy: A Report of Two Cases.异质性子宫平滑肌瘤MRI扫描中T2信号低的局灶区域不能排除恶性可能性:两例报告
Case Rep Radiol. 2025 Apr 25;2025:5388015. doi: 10.1155/crra/5388015. eCollection 2025.
2
AMH and Kisspeptin Receptor Expression in Rare Hydropic Leiomyoma: A Case Study.抗苗勒管激素(AMH)和亲吻素受体在罕见的水肿性平滑肌瘤中的表达:一项病例研究。
Am J Case Rep. 2025 Apr 30;26:e947953. doi: 10.12659/AJCR.947953.
3
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study.

本文引用的文献

1
Role of MR imaging of uterine leiomyomas before and after embolization.子宫肌瘤栓塞治疗前后的磁共振成像作用。
Radiographics. 2012 Oct;32(6):E251-81. doi: 10.1148/rg.326125517.
2
Therapeutic management of uterine fibroid tumors: updated French guidelines.子宫纤维瘤肿瘤的治疗管理:法国更新指南。
Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29.
3
Dealing with uterine fibroids in reproductive medicine.生殖医学中子宫肌瘤的处理
通过MRI和血清乳酸脱氢酶水平鉴别子宫肌瘤和肉瘤:加茂川研究的多中心研究
J Gynecol Oncol. 2025 Jul;36(4):e58. doi: 10.3802/jgo.2025.36.e58. Epub 2025 Apr 4.
4
Magnetic resonance imaging features of uterine adenosarcoma: case series and systematic review.子宫腺肉瘤的磁共振成像特征:病例系列及系统评价
Abdom Radiol (NY). 2024 Dec 27. doi: 10.1007/s00261-024-04704-y.
5
Uterine Leiomyosarcoma in a 22-Year-Old Young Woman: A Case Report.一名22岁年轻女性的子宫平滑肌肉瘤:病例报告
Cureus. 2024 Jun 10;16(6):e62087. doi: 10.7759/cureus.62087. eCollection 2024 Jun.
6
Case report: Spontaneous rupture of leiomyosarcoma uteri 8 months after primary laparoscopic surgery of STUMP.病例报告:子宫平滑肌肉瘤在 STUMP 初次腹腔镜手术后 8 个月自发破裂。
Front Med (Lausanne). 2024 May 31;11:1407546. doi: 10.3389/fmed.2024.1407546. eCollection 2024.
7
Whole Process of Standardization of Diffusion-Weighted Imaging: Phantom Validation and Clinical Application According to the QIBA Profile.扩散加权成像标准化的全过程:根据QIBA标准进行模体验证和临床应用
Diagnostics (Basel). 2024 Mar 9;14(6):583. doi: 10.3390/diagnostics14060583.
8
Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.鉴别子宫癌肉瘤与子宫内膜样腺癌的临床及多参数MRI特征
BMC Med Imaging. 2024 Feb 19;24(1):48. doi: 10.1186/s12880-024-01225-4.
9
The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.子宫肉瘤术前磁共振成像的自动诊断人工智能系统。
J Gynecol Oncol. 2024 May;35(3):e24. doi: 10.3802/jgo.2024.35.e24. Epub 2023 Dec 7.
10
Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.术前磁共振成像中利用逻辑回归分类器鉴别子宫肉瘤与非典型平滑肌瘤:扩散加权成像定量参数的附加价值。
Korean J Radiol. 2024 Jan;25(1):43-54. doi: 10.3348/kjr.2023.0760.
J Obstet Gynaecol. 2012 Apr;32(3):210-6. doi: 10.3109/01443615.2011.644357.
4
Screening for uterine tumours.子宫肿瘤筛查。
Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):257-66. doi: 10.1016/j.bpobgyn.2011.08.002. Epub 2011 Nov 9.
5
Clinical presentation and diagnosis of uterine sarcoma, including imaging.子宫肉瘤的临床表现和诊断,包括影像学检查。
Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):681-9. doi: 10.1016/j.bpobgyn.2011.07.002. Epub 2011 Aug 4.
6
Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients.磁共振引导聚焦超声治疗子宫肌瘤:130 例临床患者 12 个月的结果回顾。
J Vasc Interv Radiol. 2011 Jun;22(6):857-64. doi: 10.1016/j.jvir.2011.01.458. Epub 2011 Apr 8.
7
Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.联合使用 T2 加权和弥散加权 3-T MR 成像区分子宫肉瘤和良性平滑肌瘤。
Eur Radiol. 2009 Nov;19(11):2756-64. doi: 10.1007/s00330-009-1471-x. Epub 2009 Jun 6.
8
Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.扩散加权磁共振成像对预测附件复杂肿块良性的贡献。
Eur Radiol. 2009 Jun;19(6):1544-52. doi: 10.1007/s00330-009-1299-4. Epub 2009 Feb 13.
9
Dynamic contrast-enhanced MR imaging of ovarian neoplasms: current status and future perspectives.卵巢肿瘤的动态对比增强磁共振成像:现状与未来展望
Magn Reson Imaging Clin N Am. 2008 Nov;16(4):661-72, ix. doi: 10.1016/j.mric.2008.07.012.
10
The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.磁共振扩散加权成像在鉴别子宫肉瘤与良性平滑肌瘤中的应用。
Eur Radiol. 2008 Apr;18(4):723-30. doi: 10.1007/s00330-007-0787-7. Epub 2007 Oct 10.